You just read:

Growing Uptake of Genzyme's Aubagio at Three Months Post-Launch Is Likely Driven by Perceived Product Convenience Even As Neurologists Search to Identify Appropriate Candidates, According to a Recent BioTrends Report

News provided by

BioTrends Research Group

Mar 06, 2013, 09:00 ET